These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32079038)

  • 1. Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostification.
    Wang LQ; Kumar S; Calin GA; Li Z; Chim CS
    Br J Haematol; 2020 Jul; 190(2):249-261. PubMed ID: 32079038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
    Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
    Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
    Zhang Q; Wang LQ; Wong KY; Li ZY; Chim CS
    J Clin Pathol; 2015 Jul; 68(7):557-61. PubMed ID: 25855800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
    Li Z; Wong KY; Chan GC; Chim CS
    J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of EVL/miR-342 in multiple myeloma.
    Li Z; Wong KY; Chan GC; Chng WJ; Chim CS
    Transl Res; 2018 Feb; 192():46-53. PubMed ID: 29242101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.
    Zhang MY; Wang LQ; Chim CS
    Cell Commun Signal; 2021 May; 19(1):62. PubMed ID: 34044822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of MIR203 in multiple myeloma.
    Wong KY; Liang R; So CC; Jin DY; Costello JF; Chim CS
    Br J Haematol; 2011 Sep; 154(5):569-78. PubMed ID: 21707582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
    Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
    Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of the MIR129-2 in hematological malignancies.
    Wong KY; Yim RL; Kwong YL; Leung CY; Hui PK; Cheung F; Liang R; Jin DY; Chim CS
    J Hematol Oncol; 2013 Feb; 6():16. PubMed ID: 23406679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of the miR-124-1 in haematological malignancies.
    Wong KY; So CC; Loong F; Chung LP; Lam WW; Liang R; Li GK; Jin DY; Chim CS
    PLoS One; 2011 Apr; 6(4):e19027. PubMed ID: 21544199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of the MIR34B/C in multiple myeloma.
    Wong KY; Yim RL; So CC; Jin DY; Liang R; Chim CS
    Blood; 2011 Nov; 118(22):5901-4. PubMed ID: 21976676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma.
    Costa C; Indovina P; Mattioli E; Forte IM; Iannuzzi CA; Luzzi L; Bellan C; De Summa S; Bucci E; Di Marzo D; De Feo M; Mutti L; Pentimalli F; Giordano A
    Cell Death Dis; 2020 Sep; 11(9):748. PubMed ID: 32929059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.
    Chim CS; Wong KY; Leung CY; Chung LP; Hui PK; Chan SY; Yu L
    J Cell Mol Med; 2011 Dec; 15(12):2760-7. PubMed ID: 21323860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
    Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
    J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANKL expression in myeloma cells is regulated by a network involving RANKL promoter methylation, DNMT1, microRNA and TNFα in the microenvironment.
    Yuan L; Chan GC; Fung KL; Chim CS
    Biochim Biophys Acta; 2014 Sep; 1843(9):1834-8. PubMed ID: 24875904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
    Ng HY; Wan TS; So CC; Chim CS
    J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.
    Amodio N; Bellizzi D; Leotta M; Raimondi L; Biamonte L; D'Aquila P; Di Martino MT; Calimeri T; Rossi M; Lionetti M; Leone E; Passarino G; Neri A; Giordano A; Tagliaferri P; Tassone P
    Cell Cycle; 2013 Dec; 12(23):3650-62. PubMed ID: 24091729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.
    Tatekawa S; Chinen Y; Ri M; Narita T; Shimura Y; Matsumura-Kimoto Y; Tsukamoto T; Kobayashi T; Kawata E; Uoshima N; Taki T; Taniwaki M; Handa H; Iida S; Kuroda J
    Br J Haematol; 2017 Aug; 178(4):534-546. PubMed ID: 28439875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.
    Krzeminski P; Sarasquete ME; Misiewicz-Krzeminska I; Corral R; Corchete LA; Martín AA; García-Sanz R; San Miguel JF; Gutiérrez NC
    Biochim Biophys Acta; 2015 Mar; 1849(3):353-66. PubMed ID: 25497370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.